Gisele holds a degree in Medicine from the Federal University of Ceará (1999), a residency in Neurology from the Federal University of São Paulo (2003), a doctorate in Neurology from the Federal University of São Paulo (2005), a specialization (fellowship) in Cerebrovascular Diseases and Neurointensive Care at Harvard University/Massachusetts General Hospital (2009) and a master's degree in public health from Harvard School of Public Health (2014). She is currently a professor of Neurology at the Federal University of São Paulo and Head of Neurology Clinical Research at the Albert Einstein Hospital, São Paulo, Brazil. Gisele has been the principal investigator of numerous clinical trials in Brazil, including the RESILIENT trial, which led to the approval of mechanical thrombectomy in the Public Health System in the country. She has also held important positions in several national and international societies, such as the President of the Brazilian Stroke Society, a member of the Board of Directors for the Neurocritical Care Society, and past Secretary of the Brazilian Academy of Neurology. She is actively involved with the WSO/SIECV Certification of Stroke Centers in Latin American and Caribbean countries. She is one of the leaders of the Optimal Stroke trial, evaluating ideal blood pressure levels following ischemic stroke, which finalized the recruitment of more than 4000 patients in Brazil.
Achieving our vision of a life free from stroke is a task that WSO cannot achieve alone. We are committed to building our partnerships at the global, regional and national level to scale up and deliver improvements in prevention, treatment and support to reduce the burden of stroke.